Año: 2017
Journal Impact Factor (JIF): 4.1290
Categoría | Edición | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|---|
PHARMACOLOGY & PHARMACY | SCIE | 39/261 | Q1 | T1 | D2 |
CLINICAL NEUROLOGY | SCIE | 40/197 | Q1 | T1 | D3 |
PSYCHIATRY | SCIE | 29/142 | Q1 | T1 | D3 |
NEUROSCIENCES | SCIE | 67/261 | Q2 | T1 | D3 |
Año: 2017
Journal Citation Indicator (JCI): 1,310
Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
---|---|---|---|---|---|
CLINICAL NEUROLOGY | 35/250 | Q1 | T1 | D2 | 86,20 |
NEUROSCIENCES | 59/285 | Q1 | T1 | D3 | 79,47 |
PHARMACOLOGY & PHARMACY | 38/336 | Q1 | T1 | D2 | 88,84 |
PSYCHIATRY | 33/243 | Q1 | T1 | D2 | 86,63 |
Año:
2017
CiteScore:
8,300
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Neurology (clinical) | 31/337 | Q1 | T1 | D1 |
Pharmacology | 27/308 | Q1 | T1 | D1 |
Pharmacology (medical) | 14/238 | Q1 | T1 | D1 |
Psychiatry and Mental Health | 26/491 | Q1 | T1 | D1 |
Biological Psychiatry | 4/37 | Q1 | T1 | D2 |
Neurology | 19/146 | Q1 | T1 | D2 |
SJR año:
2017
Factor de Impacto:
1,911
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Pharmacology | 29/335 | Q1 | T1 | D1 |
Pharmacology (medical) | 16/279 | Q1 | T1 | D1 |
Psychiatry and Mental Health | 46/588 | Q1 | T1 | D1 |
Neurology | 24/170 | Q1 | T1 | D2 |
Neurology (clinical) | 39/389 | Q1 | T1 | D2 |
Biological Psychiatry | 13/45 | Q2 | T1 | D3 |
Agencia | Código de Proyecto |
---|---|
Alexza | - |
Almirall | - |
AstraZeneca | - |
Bristol-Myers Squibb | - |
Cephalon | - |
CIBERSAM | - |
Eli Lilly | - |
Ferrer | - |
Forest Research Institute | - |
Gedeon Richter | - |
GlaxoSmith-Kline | - |
Janssen | - |
Janssen-Cilag | - |
Jazz | - |
Johnson Johnson | - |
Lundbeck | - |
Merck | - |
Novartis | - |
Organon | - |
Otsuka | - |
Pfizer | - |
Pierre-Fabre | - |
Qualigen | - |
Roche | - |
Sanofi-Aventis | - |
Schering-Plough | - |
Servier | - |
Seventh European Framework Programme (ENBREC) | - |
Shire | - |
Solvay | - |
Stanley Medical Research Institute | - |
Takeda | - |
Teva | - |
United Biosource Corporation | - |
Wyeth | - |
# | Autor |
---|---|
1 | Varo, C |
2 | Jimenez, E |
3 | Sole, B |
4 | Bonnin, C |
5 | Torrent, C |
6 | Valls, E |
7 | Morilla, I |
8 | Lahera, G |
9 | Martinez-Aran, A |
10 | Vieta, E |
11 | Reinares, M |